Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT04457817
What this trial is testing

Compensatory Reserve Index (CRI) for Management of COVID-19

Who this might be right for
COVID
University of Colorado, Denver 16
Testing effectiveness (Phase 2)Ended earlyNCT05067933
What this trial is testing

A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine

Who this might be right for
COVID-19
Vaxart 66
Not applicableStudy completedNCT04841785
What this trial is testing

RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients

Who this might be right for
Covid19SARS-CoV InfectionChronic Kidney Diseases
University Medical Center Groningen 4,868
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000
Testing effectiveness (Phase 2)UnknownNCT04356482
What this trial is testing

CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19

Who this might be right for
COVID-19SARS-CoV 2Convalescence+2 more
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado 90
Testing effectiveness (Phase 2)Ended earlyNCT04969991
What this trial is testing

Study of Varespladib in Patients Hospitalized With Severe COVID-19

Who this might be right for
Coronavirus Disease 2019Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
Ophirex, Inc. 18
Not applicableStudy completedNCT04380727
What this trial is testing

Almitrine and COVID-19 Related Hypoxemia

Who this might be right for
COVID-19Hypoxic Respiratory Failure
Central Hospital, Nancy, France 17
Not applicableStudy completedNCT04673279
What this trial is testing

Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina

Who this might be right for
Coronavirus Disease 2019
Hospital Italiano de Buenos Aires 189
Large-scale testing (Phase 3)Temporarily pausedNCT04341870
What this trial is testing

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO

Who this might be right for
COVID19SARS-CoV-2 Infection
Assistance Publique - Hôpitaux de Paris 27
Not applicableStudy completedNCT04667923
What this trial is testing

Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome

Who this might be right for
Covid19ARDS
I.M. Sechenov First Moscow State Medical University 80
Not applicableStudy completedNCT04733625
What this trial is testing

The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection

Who this might be right for
Covid19SARS-CoV Infection
Kasr El Aini Hospital 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04488081
What this trial is testing

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Who this might be right for
COVID-19
QuantumLeap Healthcare Collaborative 1,500
Very early researchWithdrawnNCT04528771
What this trial is testing

S-Nitrosylation Therapy of COVID-19

Who this might be right for
SARS-CoV2 InfectionCovid19
James Reynolds
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Not applicableWithdrawnNCT04456426
What this trial is testing

Characteristics of Patients With COVID-19 in Meta State, Colombia

Who this might be right for
COVIDSARS-CoV 2SARS Pneumonia+2 more
Hospital Departamental de Villavicencio
Not applicableStudy completedNCT05894499
What this trial is testing

Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,309
Testing effectiveness (Phase 2)Study completedNCT04561063
What this trial is testing

COVID-19 Prophylaxis South Africa (COVER HCW)

Who this might be right for
Covid19SARS-CoV Infection
University of Witwatersrand, South Africa 1,950
Not applicableStudy completedNCT05439044
What this trial is testing

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Who this might be right for
Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris 4,235
Testing effectiveness (Phase 2)Study completedNCT04312009
What this trial is testing

Losartan for Patients With COVID-19 Requiring Hospitalization

Who this might be right for
Corona Virus InfectionAcute Respiratory Distress SyndromeSARS-CoV Infection
University of Minnesota 205
Not applicableEnded earlyNCT04361344
What this trial is testing

Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection

Who this might be right for
COVID-19 InfectionEncephalitis
Centre Hospitalier de PAU 2
Next Page